Clinical trials of treatment for noncognitive symptoms of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

被引：0
|
作者：
Homma, A
Brodaty, H
Bruno, G
Cummings, JL
Gilman, S
Gracon, S
McKeith, IG
机构：
[1] PRINCE HENRY HOSP,ACAD DEPT PSYCHOGERIATR,LITTLE BAY,NSW 2036,AUSTRALIA
[2] UNIV ROMA LA SAPIENZA,DEPT NEUROL SCI,I-00185 ROME,ITALY
[3] UNIV CALIF LOS ANGELES,DEPT NEUROL,LOS ANGELES,CA 90024
[4] WARNER LAMBERT PARKE DAVIS,ANN ARBOR,MI 48105
[5] NEWCASTLE GEN HOSP,INST HLTH ELDERLY,DEPT OLD AGE PSYCHIAT,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND
来源：
ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 1997年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [1] Diagnostic criteria for dementia in clinical trials - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Antuono, P
    Doody, R
    Gilman, S
    Huff, J
    Scheltens, P
    Ueda, K
    Khachaturian, ZS
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 22 - 25
  • [2] Length of clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Levy, R
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 33 - 33
  • [3] Translation issues in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Feldman, H
    Anand, R
    Blesa, R
    Dubois, B
    Gray, J
    Homma, A
    Mohr, E
    Morris, JC
    Parys, W
    Raschig, A
    Robillard, A
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 61 - 64
  • [4] Clinical global measures of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Reisberg, B
    Schneider, L
    Doody, R
    Anand, R
    Feldman, H
    Haraguchi, H
    Kumar, R
    Lucca, U
    Mangone, CA
    Mohr, E
    Morris, JC
    Rogers, S
    Sawada, T
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 8 - 18
  • [5] Objective psychometric tests in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Ferris, SH
    Lucca, U
    Mohs, R
    Dubois, B
    Wesnes, K
    Erzigkeit, H
    Geldmacher, D
    Bodick, N
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 34 - 38
  • [6] Issues in the economic evaluation of treatment for dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Winblad, B
    Hill, S
    Beermann, B
    Post, SG
    Wimo, A
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 39 - 45
  • [7] Ethical issues in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Post, SG
    Beerman, B
    Brodaty, H
    Gaines, AW
    Gauthier, SG
    Geldmacher, DS
    Hill, S
    Homma, A
    Rossor, MN
    Whitehouse, PJ
    Winblad, B
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 26 - 28
  • [8] Activities of daily living as an outcome measure in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Gauthier, S
    Bodick, N
    Erzigkeit, E
    Feldman, H
    Geldmacher, DS
    Huff, J
    Mohs, R
    Orgogozo, JM
    Rogers, S
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 6 - 7
  • [9] Quality-of-life assessment in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Whitehouse, PJ
    Orgogozo, JM
    Becker, RE
    Gauthier, S
    Pontecorvo, M
    Erzigkeit, H
    Rogers, S
    Mohs, RC
    Bodick, N
    Bruno, G
    DalBianco, P
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 56 - 60
  • [10] Prevention protocols for Alzheimer disease - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Thal, LJ
    Carta, A
    Doody, R
    Leber, P
    Mohs, R
    Schneider, L
    Shimohama, S
    Silber, C
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 46 - 49
12345